These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33992496)

  • 1. Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI).
    Obi ON; Judson MA; Birring SS; Maier LA; Wells AU; Lower EE; Baughman RP
    Respir Med; 2022 Jan; 191():106436. PubMed ID: 33992496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD.
    de Torres JP; Pinto-Plata V; Ingenito E; Bagley P; Gray A; Berger R; Celli B
    Chest; 2002 Apr; 121(4):1092-8. PubMed ID: 11948037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyspnea in COPD: beyond the modified Medical Research Council scale.
    Camargo LA; Pereira CA
    J Bras Pneumol; 2010; 36(5):571-8. PubMed ID: 21085822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation study of the BDI/TDI scores in chronic obstructive pulmonary disease].
    Laurendeau C; Pribil C; Perez T; Roche N; Simeoni MC; Detournay B
    Rev Mal Respir; 2009 Sep; 26(7):735-43. PubMed ID: 19953015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
    Tabberer M; Brooks J; Wilcox T
    Health Qual Life Outcomes; 2015 Oct; 13():177. PubMed ID: 26520062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ways to quantify dyspnea severity. Part I. Baseline Dyspnea Index (BDI), Transition Dyspnea Index (TDI)].
    Nemeş R; Bumbăcea D
    Pneumologia; 2006; 55(2):58-63. PubMed ID: 17069203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of dyspnea in quality of life of the patient with chronic obstructive pulmonary disease].
    Elías Hernández MT; Ortega Ruiz F; Sánchez Riera H; Otero Candelera R; Sánchez Gil R; Montemayor Rubio T
    Arch Bronconeumol; 1999 Jun; 35(6):261-6. PubMed ID: 10410205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease.
    Chhabra SK; Gupta AK; Khuma MZ
    Ann Thorac Med; 2009 Jul; 4(3):128-32. PubMed ID: 19641643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical assessment tests in evaluating patients with chronic obstructive pulmonary disease: A cross-sectional study.
    Chuang ML; Lin IF; Lee CY
    Medicine (Baltimore); 2016 Nov; 95(47):e5471. PubMed ID: 27893695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of a Self-administered Questionnaire Version of the Transition Dyspnea Index in Patients with COPD.
    von Leupoldt A; Reijnders T; Schuler M; Wittmann M; Jelusic D; Schultz K
    COPD; 2017 Feb; 14(1):66-71. PubMed ID: 27841688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis.
    Gvozdenovic BS; Mihailovic-Vucinic V; Ilic-Dudvarski A; Zugic V; Judson MA
    Respir Med; 2008 Nov; 102(11):1636-42. PubMed ID: 18691860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor analysis of laboratory and clinical measurements of dyspnea in patients with chronic obstructive pulmonary disease.
    Nguyen HQ; Altinger J; Carrieri-Kohlman V; Gormley JM; Stulbarg MS
    J Pain Symptom Manage; 2003 Feb; 25(2):118-27. PubMed ID: 12590027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between disease severity and quality of life in patients with chronic obstructive pulmonary disease.
    Sanchez FF; Faganello MM; Tanni SE; Lucheta PA; Padovani CR; Godoy I
    Braz J Med Biol Res; 2008 Oct; 41(10):860-5. PubMed ID: 19037530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The St. George's Respiratory Questionnaire in Pulmonary Sarcoidosis.
    Lo KH; Donohue J; Judson MA; Wu Y; Barnathan ES; Baughman RP;
    Lung; 2020 Dec; 198(6):917-924. PubMed ID: 32979072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation.
    Aaron SD; Vandemheen KL; Clinch JJ; Ahuja J; Brison RJ; Dickinson G; Hébert PC
    Chest; 2002 Mar; 121(3):688-96. PubMed ID: 11888946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of dyspnoea and leg fatigue during exercise on health-related quality of life in patients with COPD.
    Katsura H; Yamada K; Wakabayashi R; Kida K
    Respirology; 2005 Sep; 10(4):485-90. PubMed ID: 16135172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The evaluation of dyspnea and quality of life in COPD].
    Demir G; Akkoca O; Doğan R; Saryal S; Karabiyikoğlu G
    Tuberk Toraks; 2003; 51(4):365-72. PubMed ID: 15143383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyspnea-induced Limitation (DYSLIM), a new self-administered concise questionnaire to evaluate dyspnea-related activity limitation in chronic respiratory diseases.
    Perez T; Roche N; Nunes H; Burgel PR; Chaouat A; Surpas P; Herengt F; Garcia G; Grosbois JM; Stelianides S; de Rigal P; Guérin P; Arnould B; Coste J
    Respir Med; 2023 Oct; 217():107309. PubMed ID: 37394196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.